October 2019

ISOPP Global Position on the Use of Biosimilars in Cancer Treatment and Supportive Care

October 10, 2019

This position statement, developed by the ISOPP Biosimilars Taskforce, aims to provide the global oncology pharmacy community with guidance to support decisions around biosimilar use.

 
Read more